Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAP1LC3A Antikörper (C-Term)

MAP1LC3A Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB7485 unconjugated
Produktnummer ABIN388474
  • Target Alle MAP1LC3A Antikörper anzeigen
    MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))
    Bindungsspezifität
    • 23
    • 21
    • 20
    • 15
    • 13
    • 11
    • 11
    • 10
    • 9
    • 8
    • 8
    • 7
    • 7
    • 7
    • 7
    • 6
    • 6
    • 6
    • 5
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 77-106, C-Term
    Reaktivität
    • 211
    • 106
    • 87
    • 12
    • 9
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 173
    • 44
    • 2
    Kaninchen
    Klonalität
    • 165
    • 54
    Polyklonal
    Konjugat
    • 108
    • 18
    • 15
    • 14
    • 14
    • 13
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Dieser MAP1LC3A Antikörper ist unkonjugiert
    Applikation
    • 197
    • 95
    • 73
    • 47
    • 33
    • 31
    • 29
    • 14
    • 14
    • 13
    • 11
    • 10
    • 9
    • 6
    • 5
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Aufreinigung
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
    Immunogen
    This LC3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 77-106 amino acids from the C-terminal region of human LC3.
    Klon
    RB7485
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product MAP1LC3A Primärantikörper
  • Applikationshinweise
    WB: 1:1000. IHC-P: 1:50~100. IHC-P: 1:50~100
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Haltbarkeit
    6 months
  • Eng, Panas, Karlsson Hedestam, McInerney: "A novel quantitative flow cytometry-based assay for autophagy." in: Autophagy, Vol. 6, Issue 5, pp. 634-41, (2012) (PubMed).

    Ryu, Kim, Yeo, Kang: "p65/RelA-Ser529 NF-?B subunit phosphorylation induces autophagic astroglial death (Clasmatodendrosis) following status epilepticus." in: Cellular and molecular neurobiology, Vol. 31, Issue 7, pp. 1071-8, (2011) (PubMed).

    Li, Wang, Fei, Xia, Qin, Liang: "Parkinson's disease involves autophagy and abnormal distribution of cathepsin L." in: Neuroscience letters, Vol. 489, Issue 1, pp. 62-7, (2011) (PubMed).

    Zhuang, Li, Long, Chen, Huang, Liang: "Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy." in: Brain research, Vol. 1371, pp. 7-15, (2011) (PubMed).

    Bartlett, Isakson, Lewerenz, Sanchez, Kotzebue, Cumming, Harris, Nezis, Schubert, Simonsen, Finley: "p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects." in: Autophagy, Vol. 7, Issue 6, pp. 572-83, (2011) (PubMed).

    Arnold, Cassady, VanLaar, Berman: "Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model." in: Neurobiology of disease, Vol. 41, Issue 1, pp. 189-200, (2010) (PubMed).

    Calakos, Patel, Gottron, Wang, Tran-Viet, Brewington, Beyer, Steffens, Krishnan, Züchner: "Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia." in: Journal of medical genetics, Vol. 47, Issue 9, pp. 646-50, (2010) (PubMed).

    Cherra, Kulich, Uechi, Balasubramani, Mountzouris, Day, Chu: "Regulation of the autophagy protein LC3 by phosphorylation." in: The Journal of cell biology, Vol. 190, Issue 4, pp. 533-9, (2010) (PubMed).

    Yang, Liu, Goga, Kim, Yuneva, Bishop: "Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Issue 31, pp. 13836-41, (2010) (PubMed).

    Wang, Gorvel, Chu, Wu, Lei: "Helicobacter pylori impairs murine dendritic cell responses to infection." in: PLoS ONE, Vol. 5, Issue 5, pp. e10844, (2010) (PubMed).

    Caramés, Taniguchi, Otsuki, Blanco, Lotz: "Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis." in: Arthritis and rheumatism, Vol. 62, Issue 3, pp. 791-801, (2010) (PubMed).

    Ren, He, Nong, Zhu, Hu, Zhang, Huang, Zhu, Wu: "Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy." in: Cancer biotherapy & radiopharmaceuticals, Vol. 25, Issue 1, pp. 75-80, (2010) (PubMed).

  • Target
    MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))
    Andere Bezeichnung
    LC3 (MAP1LC3A Produkte)
    Synonyme
    ATG8E antikoerper, LC3 antikoerper, LC3A antikoerper, MAP1ALC3 antikoerper, MAP1BLC3 antikoerper, 1010001H21Rik antikoerper, 4922501H04Rik antikoerper, LC3a antikoerper, MGC69006 antikoerper, zgc:77094 antikoerper, MGC89867 antikoerper, MAP1LC3A antikoerper, map1lc3a antikoerper, microtubule associated protein 1 light chain 3 alpha antikoerper, microtubule-associated protein 1 light chain 3 alpha antikoerper, microtubule associated protein 1 light chain 3 alpha S homeolog antikoerper, MAP1LC3A antikoerper, Map1lc3a antikoerper, map1lc3a.S antikoerper, map1lc3a antikoerper
    Hintergrund
    Macroautophagy is the major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells, it is also responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation. Macroautophagy involves the formation of double-membrane bound autophagosomes which enclose the cytoplasmic constituent targeted for degradation in a membrane bound structure, which then fuse with the lysosome (or vacuole) releasing a single-membrane bound autophagic bodies which are then degraded within the lysosome (or vacuole). MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. These proteins are involved in formation of autophagosomal vacuoles (autophagosomes). MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. MAP1LC3b is one of the light chain subunits and can associate with either MAP1A or MAP1B. The precursor molecule is cleaved by APG4B/ATG4B to form the cytosolic form, LC3-I. This is activated by APG7L/ATG7, transferred to ATG3 and conjugated to phospholipid to form the membrane-bound form, LC3-II.
    Molekulargewicht
    14688
    Gen-ID
    81631
    NCBI Accession
    NP_073729
    UniProt
    Q9GZQ8
    Pathways
    Autophagie
Sie sind hier:
Kundenservice